迪奥斯基宁的抗癌潜力,一个类固醇沙宁,对人类口腔癌细胞
Uma Dutta1, Sonali Dey1, Monikongkona Boruah2
1Cell and Molecular Biology, Toxicology Laboratory, Department of Zoology, Cotton University, Guwahati, Assam, India.
Asian Pacific journal of cancer prevention : APJCP
|June 21, 2025
概括
天然化合物迪奥斯基宁在治疗口腔状细胞癌 (OSCC) 方面表现有前途,通过抑制癌细胞的生长和迁移. 它还增强了现有的化疗药物对OSCC的有效性.
科学领域:
- 在瘤学瘤学.
- 自然产品化学 自然产品化学
- 分子生物学分子生物学
背景情况:
- 口腔状细胞癌 (OSCC) 是全球流行的一种癌症,印度东北部的发病率很高.
- 目前的手术和化疗等治疗方法存在局限性,包括副作用和对诸如西斯和5-甲 (5-FU) 等药物的化学抵抗.
- 迪奥斯基宁,一种类固醇的素,正在研究其潜在的治疗效果.
研究的目的:
- 为了研究体内迪奥斯基宁对OSCC细胞的存活,增殖和迁移的影响.
- 评估迪奥斯基宁对OSCC细胞对西斯丁和5-FU的化学敏感性的影响.
- 评估迪奥斯基宁对参与OSCC进展的关键蛋白质的表达的影响.
主要方法:
- 在体外测试包括MTT,殖民地形成,细胞周期分析 (PI-FACS),活/死染色和伤口愈合测试.
- 西部斑点分析用于评估与OSCC相关的关键蛋白质的表达.
- 在OSCC细胞系 (SAS,HSC3) 和正常细胞系 (HEK-293T) 上测试了迪奥斯基宁的作用.
主要成果:
- 迪奥斯基宁对OSCC细胞系 (SAS,HSC3) 具有选择性抗增殖活性,但对正常的HEK-293T细胞没有.
- 迪奥斯基宁增强了SAS细胞对思丁和5-FU的化学敏感性.
- 该化合物对SAS细胞表现出剂量依赖的抗克隆原,细胞循环停止,细胞毒性和抗迁移作用,并调节了关键OSCC蛋白 (COX-2,CXCR-4,VEGF,TWIST-1,p-AKT,AKT).
结论:
- 迪奥斯基宁在治疗口腔癌方面显示出显著的治疗潜力.
- 这些发现表明迪奥斯基宁是新型口腔癌治疗的有希望的候选者.
- 需要在体内和临床环境中进一步验证.
更多相关视频
14:18Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
Published on: October 13, 2023
1.9K
09:03Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
Published on: January 26, 2024
476
相关概念视频
Cancer Prevention
6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.3K
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Mutagenicity and Carcinogenicity
1.4K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K
